48 related articles for article (PubMed ID: 15315965)
1. Defective B cell responses in the absence of SH2D1A.
Morra M; Barrington RA; Abadia-Molina AC; Okamoto S; Julien A; Gullo C; Kalsy A; Edwards MJ; Chen G; Spolski R; Leonard WJ; Huber BT; Borrow P; Biron CA; Satoskar AR; Carroll MC; Terhorst C
Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4819-23. PubMed ID: 15774582
[TBL] [Abstract][Full Text] [Related]
2. Follicular helper CD4 T cells (TFH).
Crotty S
Annu Rev Immunol; 2011; 29():621-63. PubMed ID: 21314428
[TBL] [Abstract][Full Text] [Related]
3. SLAM Family Receptors in B Cell Chronic Lymphoproliferative Disorders.
Kľoc D; Kurhajec S; Huniadi M; Sýkora J; Guman T; Šarišský M
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612827
[TBL] [Abstract][Full Text] [Related]
4. SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy.
Farhangnia P; Ghomi SM; Mollazadehghomi S; Nickho H; Akbarpour M; Delbandi AA
Front Immunol; 2023; 14():1174138. PubMed ID: 37251372
[TBL] [Abstract][Full Text] [Related]
5. Screening and Prognostic Analysis of Immune-Related Genes in Pancreatic Cancer.
Wu X; Liang Y
Front Genet; 2021; 12():721419. PubMed ID: 34737763
[TBL] [Abstract][Full Text] [Related]
6. SLAMF1 contributes to cell survival through the AKT signaling pathway in Farage cells.
Yoon H; Kim EK; Ko YH
PLoS One; 2020; 15(9):e0238791. PubMed ID: 32886706
[TBL] [Abstract][Full Text] [Related]
7. The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling.
Gordiienko I; Shlapatska L; Kholodniuk V; Sklyarenko L; Gluzman DF; Clark EA; Sidorenko SP
PLoS One; 2017; 12(10):e0185940. PubMed ID: 28982149
[TBL] [Abstract][Full Text] [Related]
8. Measles virus hemagglutinin triggers intracellular signaling in CD150-expressing dendritic cells and inhibits immune response.
Romanets-Korbut O; Kovalevska LM; Seya T; Sidorenko SP; Horvat B
Cell Mol Immunol; 2016 Nov; 13(6):828-838. PubMed ID: 26073466
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD150 in tumors of the central nervous system: identification of a novel isoform.
Romanets-Korbut O; Najakshin AM; Yurchenko M; Malysheva TA; Kovalevska L; Shlapatska LM; Zozulya YA; Taranin AV; Horvat B; Sidorenko SP
PLoS One; 2015; 10(2):e0118302. PubMed ID: 25710480
[TBL] [Abstract][Full Text] [Related]
10. The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells: activation mechanisms, regulation and impact on cellular functions.
Pauls SD; Lafarge ST; Landego I; Zhang T; Marshall AJ
Front Immunol; 2012; 3():224. PubMed ID: 22908014
[TBL] [Abstract][Full Text] [Related]
11. Essential role of EBF1 in the generation and function of distinct mature B cell types.
Vilagos B; Hoffmann M; Souabni A; Sun Q; Werner B; Medvedovic J; Bilic I; Minnich M; Axelsson E; Jaritz M; Busslinger M
J Exp Med; 2012 Apr; 209(4):775-92. PubMed ID: 22473956
[TBL] [Abstract][Full Text] [Related]
12. Cytoskeletal dynamics: concepts in measles virus replication and immunomodulation.
Avota E; Gassert E; Schneider-Schaulies S
Viruses; 2011 Feb; 3(2):102-117. PubMed ID: 22049305
[TBL] [Abstract][Full Text] [Related]
13. 2B4 utilizes ITAM-containing receptor complexes to initiate intracellular signaling and cytolysis.
Bida AT; Upshaw Neff JL; Dick CJ; Schoon RA; Brickshawana A; Chini CC; Billadeau DD
Mol Immunol; 2011 May; 48(9-10):1149-59. PubMed ID: 21439641
[TBL] [Abstract][Full Text] [Related]
14. Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib.
Messmer D; Fecteau JF; O'Hayre M; Bharati IS; Handel TM; Kipps TJ
Blood; 2011 Jan; 117(3):882-9. PubMed ID: 21079155
[TBL] [Abstract][Full Text] [Related]
15. SAP enables T cells to help B cells by a mechanism distinct from Th cell programming or CD40 ligand regulation.
Kamperschroer C; Roberts DM; Zhang Y; Weng NP; Swain SL
J Immunol; 2008 Sep; 181(6):3994-4003. PubMed ID: 18768854
[TBL] [Abstract][Full Text] [Related]
16. The adaptor protein SH2D1A regulates signaling through CD150 (SLAM) in B cells.
Mikhalap SV; Shlapatska LM; Yurchenko OV; Yurchenko MY; Berdova GG; Nichols KE; Clark EA; Sidorenko SP
Blood; 2004 Dec; 104(13):4063-70. PubMed ID: 15315965
[TBL] [Abstract][Full Text] [Related]
17. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A.
Shlapatska LM; Mikhalap SV; Berdova AG; Zelensky OM; Yun TJ; Nichols KE; Clark EA; Sidorenko SP
J Immunol; 2001 May; 166(9):5480-7. PubMed ID: 11313386
[TBL] [Abstract][Full Text] [Related]
18. The role of CD150-SH2D1A association in CD150 signaling in Hodgkin's lymphoma cell lines.
Yurchenko MY; Kashuba EV; Shlapatska LM; Sivkovich SA; Sidorenko SP
Exp Oncol; 2005 Mar; 27(1):24-30. PubMed ID: 15812353
[TBL] [Abstract][Full Text] [Related]
19. The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon gamma production.
Howie D; Okamoto S; Rietdijk S; Clarke K; Wang N; Gullo C; Bruggeman JP; Manning S; Coyle AJ; Greenfield E; Kuchroo V; Terhorst C
Blood; 2002 Oct; 100(8):2899-907. PubMed ID: 12351401
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
